Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aslam H Anis

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 16, 2004
National pharmacare: a dog's taleAslam H Anis
Pharmacoeconomics|March 19, 2014
Health-related productivity loss: NICE to recognize soon, good to discuss nowWei Zhang, Aslam H Anis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 27, 2009
Medical profiteering: the economics of methadone dispensationBohdan Nosyk, Aslam H Anis
Arthritis and Rheumatism|October 31, 2009
Health insurance and out-of-pocket expensesWei Zhang, Aslam H Anis
Clinical Rheumatology|March 2, 2011
The economic burden of rheumatoid arthritis: beyond health care costsWei Zhang, Aslam H Anis
Journal of Occupational and Environmental Medicine|August 28, 2010
Work productivity among employed Canadians with arthritisWei Zhang, Mieke Koehoorn, Aslam H Anis
Social Science & Medicine (1982)|December 15, 2010
Measuring and valuing productivity loss due to poor health: A critical reviewWei Zhang, Nick Bansback, Aslam H Anis
The Journal of Rheumatology|August 4, 2004
Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residentsSonia Singh, Huiying Sun, Aslam H Anis
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritisNick Bansback, Alan Brennan, Aslam H Anis
Medical Care|January 25, 2003
Lowering generic drug prices: less regulation equals more competitionAslam H Anis, Daphne P Guh, John Woolcott
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 16, 2004
National pharmacare: a dog's taleAslam H Anis
Pharmacoeconomics|March 19, 2014
Health-related productivity loss: NICE to recognize soon, good to discuss nowWei Zhang, Aslam H Anis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 27, 2009
Medical profiteering: the economics of methadone dispensationBohdan Nosyk, Aslam H Anis
Arthritis and Rheumatism|October 31, 2009
Health insurance and out-of-pocket expensesWei Zhang, Aslam H Anis
Clinical Rheumatology|March 2, 2011
The economic burden of rheumatoid arthritis: beyond health care costsWei Zhang, Aslam H Anis
Journal of Occupational and Environmental Medicine|August 28, 2010
Work productivity among employed Canadians with arthritisWei Zhang, Mieke Koehoorn, Aslam H Anis
Social Science & Medicine (1982)|December 15, 2010
Measuring and valuing productivity loss due to poor health: A critical reviewWei Zhang, Nick Bansback, Aslam H Anis
The Journal of Rheumatology|August 4, 2004
Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residentsSonia Singh, Huiying Sun, Aslam H Anis
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritisNick Bansback, Alan Brennan, Aslam H Anis
Medical Care|January 25, 2003
Lowering generic drug prices: less regulation equals more competitionAslam H Anis, Daphne P Guh, John Woolcott
Pageof 18